1-74041292-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105659.2(LRRIQ3):āc.1639G>Cā(p.Glu547Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,612,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001105659.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRIQ3 | NM_001105659.2 | c.1639G>C | p.Glu547Gln | missense_variant | 7/8 | ENST00000354431.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRIQ3 | ENST00000354431.9 | c.1639G>C | p.Glu547Gln | missense_variant | 7/8 | 5 | NM_001105659.2 | P2 | |
LRRIQ3 | ENST00000395089.5 | c.1639G>C | p.Glu547Gln | missense_variant | 6/7 | 5 | P2 | ||
LRRIQ3 | ENST00000417067.5 | c.131-14323G>C | intron_variant | 2 | |||||
LRRIQ3 | ENST00000415760.5 | c.*2703+399G>C | intron_variant, NMD_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151982Hom.: 0 Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460620Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726518
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151982Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74226
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.1639G>C (p.E547Q) alteration is located in exon 7 (coding exon 6) of the LRRIQ3 gene. This alteration results from a G to C substitution at nucleotide position 1639, causing the glutamic acid (E) at amino acid position 547 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at